Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increased Use of Infusion Pumps for the Delivery of Drugs and Other Fluids.
4.2.2 Rising Prevalence of Chronic and Fatal Diseases
4.2.3 High Demand of the Infusion Systems in the Military Medical Units.
4.2.4 Technological Advancements from the Leading Market Players
4.3 Restraint
4.3.1 Patient Safety Concerns and Improper Infusion Leading to the Severe Consequences.
4.3.2 Unmet Medical Needs in the Low Income Countries
4.4 Opportunity
4.4.1 Growing Geriatric Population Presents Significant Growth Opportunity
4.4.2 Low Income Economies and Developing Nations With Improving Healthcare Facilities Present a Great Opportunity.
4.5 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porters Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Pricing Analysis
5.3 Upcoming Trends
6 Global Infusion Pump Market, By Type
6.1 Introduction
6.1.1 Volumetric Pump
6.1.2 Syringe Pump
6.1.3 Ambulatory Pump
7 Global Infusion Pump Market, By Application
7.1 Introduction
7.2 Chemotherapy
7.3 Diabetes
7.4 Gastrointestinal Disorders
7.5 Pediatrics
7.6 Other Applications
8 Global Infusion Pump Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers
8.4 Homecare
9 Global Infusion Pump Market, By Region
9.1 Introduction
9.2 North America
9.2.1 Introduction
9.2.2 US
9.2.3 Canada
9.3 Europe
9.3.1 Introduction
9.3.2 Germany
9.3.3 France
9.3.4 UK
9.3.5 Italy
9.3.6 Spain
9.3.7 Rest Of Western Europe
9.3.8 Eastern Europe
9.4 Asia-Pacific
9.4.1 Introduction
9.4.2 Japan
9.4.3 China
9.4.4 India
9.4.5 Republic of Korea
9.4.6 Australia
9.4.7 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Introduction
9.5.2 Middle East
9.5.3 Africa
10 Company Landscape
10.1 Company Share Analysis
10.2 Competitive Landscape
10.2.1 Product Launch/Development
10.2.2 Partnerships & Collaborations
10.2.3 Acquisition
11 Company Profile
11.1 3M
11.1.1 Overview
11.1.2 Product Overview
11.1.3 Financial Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Baxter
11.2.1 Company Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financial Overview
11.2.4 Key Development
11.2.5 SWOT Analysis
11.4 Becton, Dickinson and Company
11.4.1 Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Updates
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 B. Braun Melsungen AG
11.5.1 Overview
11.5.2 Product/Business Segment Overview
11.5.3 Financial Overview
11.5.4 Key Development
11.5.5 SWOT Analysis
11.6 Fresenius Kabi AG
11.6.1 Company Overview
11.6.2 Product/Business Segment Overview
11.6.3 Financial Overview
11.6.4 Key Development
11.6.5 SWOT Analysis
11.7 ICU Medical, Inc
11.7.1 Company overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Development
11.7.1 SWOT Analysis
11.8 Smiths Medical
11.8.1 Company Overview
11.8.2 Product Overview
11.8.3 Financial Overview
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Terumo Medical Corporation
11.9.1 Company Overview
11.9.2 Product Overview
11.9.3 Financial Overview
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.1 Zyno Medical
11.10.1 Company Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis